Similar Papers

Paper Title
Journal
Date
Author
Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy
Parham Jabbarzadeh Kaboli ... Zhangang Xiao
Pharmacological Research | VOL. 156
Parham Jabbarzadeh Kaboli, et. al.Parham Jabbarzadeh Kaboli ... Zhangang Xiao
12 Apr 2020
Abstract P3-14-07: Intra-cellular dsRNA receptor RIG-I: A ubiquitous novel target for treatment of chemotherapy drug resistant breast cancer
B Jasani ... P Barrett-Lee
Cancer Research | VOL. 76
B Jasani, et. al.B Jasani ... P Barrett-Lee
15 Feb 2016
Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer
Ramarao Malla ... Mohammad Amjad Kamal
Journal of Pharmaceutical Analysis | VOL. 12
Ramarao Malla, et. al.Ramarao Malla ... Mohammad Amjad Kamal
10 Nov 2021
Functional miRNAs in breast cancer drug resistance.
Weizi Hu ... Guangqin Zhang
OncoTargets and Therapy | VOL. 11
Weizi Hu, et. al.Weizi Hu ... Guangqin Zhang
01 Mar 2018
View more papers

More From: Journal of Controlled Release

Paper Title
Journal
Date
Author
Sonopermeation combined with stroma normalization enables complete cure using nano-immunotherapy in murine breast tumors
Constantina Neophytou ... Fotios Mpekris
Journal of Controlled Release | VOL. -
Constantina Neophytou, et. al.Constantina Neophytou ... Fotios Mpekris
01 Apr 2025
Developments of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid
Lingxin Meng ... Zhide Guo
Journal of Controlled Release | VOL. -
Lingxin Meng, et. al.Lingxin Meng ... Zhide Guo
01 Apr 2025
Outside Front Cover: Yisheng Peng et al
-
Journal of Controlled Release | VOL. -
--
01 Apr 2025
Leech bionic Hirudin fusion protein prodrug loaded microneedles for long-term inhibition of thrombosis
Xue Tian ... Tianyue Jiang
Journal of Controlled Release | VOL. -
Xue Tian, et. al.Xue Tian ... Tianyue Jiang
01 Apr 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.